Clinical trial for Smoking
Official title Implementation of Transcranial Magnetic Stimulation for Smoking Cessation
ClinicalTrials.gov ID: NCT06346028
What this study is testing
- What it's testing
- This study is looking at how well a brain stimulation tool works for quitting. It also checks if it is easy to offer in a clinic.
- Who it's for
- You may be able to join if you smoke every day.
- What's involved
- You would get a gentle magnetic pulse to your head. This happens in a clinic with a medical team nearby.
- Time commitment
- The study lasts six weeks with daily visits for three weeks.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70. Healthy volunteers may be eligible.
You may be able to join if
- Patients receiving rTMS
- Smoking cigarettes daily (self-reported) Health care providers
- Currently employed as a HCP (physician, social worker, occupational therapist, etc.) at the CAMH NDC
- Involved in the care of at least 1 patient who has received rTMS for smoking cessation
You likely can't join if
- Patients receiving rTMS
- Have any intracranial implant (e.g., aneurysm clips) or any other metal object within or near the head, excluding the mouth, that cannot be safely...
- Pregnant or intending to be pregnant during the study.
- A history of a primary seizure disorder, seizure associated with an intracranial lesion, recurrent seizures related to substance intoxication or...
- Taking any anticonvulsant medication unless it cannot be tapered or discontinued due to risk of clinical safety or destabilization, according to the...
- Taking benzodiazepines with dose equivalent or greater than lorazepam 2mg/day unless it cannot be tapered or discontinued due to risk of clinical...
See the full eligibility criteria
- Patients receiving rTMS
- Smoking cigarettes daily (self-reported) Health care providers
- Currently employed as a HCP (physician, social worker, occupational therapist, etc.) at the CAMH NDC
- Involved in the care of at least 1 patient who has received rTMS for smoking cessation
- Patients receiving rTMS
- Have any intracranial implant (e.g., aneurysm clips) or any other metal object within or near the head, excluding the mouth, that cannot be safely removed.
- Pregnant or intending to be pregnant during the study.
- A history of a primary seizure disorder, seizure associated with an intracranial lesion, recurrent seizures related to substance intoxication or withdrawal or recent seizure within the last 6 months.
- Taking any anticonvulsant medication unless it cannot be tapered or discontinued due to risk of clinical safety or destabilization, according to the participant or their referring physician.
- Taking benzodiazepines with dose equivalent or greater than lorazepam 2mg/day unless it cannot be tapered or discontinued due to risk of clinical safety or destabilization, according to the participant or their...
- Space occupying intracranial lesion.
- Acutely unstable medical, psychiatric, or substance use disorder comorbidity with safety concerns at the discretion of the PI or study physician.
The study team makes the final eligibility decision.
Where it is enrolling
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Toronto, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.